Oct 6 (Reuters) - Jaguar Animal Health Inc
* Jaguar Animal Health and Napo Pharmaceuticals announce details for proposed merger
* Announcing that Aspire Capital Fund LLC purchased 348,601 shares of Jaguar common stock, at a price per share of $2.28
* As of October 1, 2016, Napo owned 22.6% of Jaguar’s outstanding shares of common stock.
* LOI contemplates a 3-to-1 Napo-to-Jaguar value ratio
* LOI also outlines capitalization requirements that napo would be required to satisfy to proceed with a potential merger Source text for Eikon: Further company coverage: